T-cell immunosenescence and its clinical relevance in man

Reviews in Clinical Gerontology

Volumn 8, Issue 1, 1998, Pages 5-14

  Remarque, Ed ^a   Pawelec, Graham ^b,c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON;

AGED; AGING; ANTIBODY RESPONSE; B LYMPHOCYTE; CELL DAMAGE; CELL DIVISION; CELL METABOLISM; CELL PROTECTION; CLINICAL RESEARCH; HEMATOPOIETIC SYSTEM; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGICAL MEMORY; IMMUNOREGULATION; IMMUNOSENESCENCE; INFECTION SENSITIVITY; MEMORY CELL; MORTALITY; NATURAL KILLER CELL; REVIEW; STEM CELL; T LYMPHOCYTE; THYMUS ATROPHY;

EID: 0031920023     PISSN: 09592598     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0959259898008028     Document Type: Review

References (100)

1. Shock NW. Physiological and chronological age. In: Dietz AA ed. Aging, its chemistry. Washington, DC: American Association for Clinical Chemistry, 1980: 3-49.
2. Ligthart GJ, Corberand JX, Hart R et al. Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech Ageing Dev 1984; 28: 47-55.
3. Ligthart GJ, Corberand JX, Geertzen HGM, Meinders AE, Knook DL, Hijmans W. Necessity of the assessment of health status in human immunogerontological studies: evaluation of the SENIEUR protocol. Mech Ageing Dev 1990; 55: 89-105.
4. Horiuchi S, Wilmoth JR. Age patterns of the life table aging rate for major causes of death in Japan, 1951-1990. J Gerontol Ser A - Biol Sci Med 1997; 52: B67-77.
5. Roberts-Thomson IC, Whittingham S, Young-Chaiyud U, Mackay IR. Ageing, immune response and mortality. Lancet 1974; 2: 368-70.
6. Murasko DM, Weiner P, Kaye D. Association of lack of mitogen-induced lymphocyte proliferation with increased mortality in the elderly. Aging Immunol Infect Dis 1988; 1: 1-6.
7. Wayne SJ, Rhyne RL, Garry PJ, Goodwin JS. Cell-mediated immunity as a predictor of morbidity and mortality in subjects over 60. J Gerontol 1990; 45: 45-48.
8. Ferguson FG, Wikby A, Maxson P, Olsson J, Johansson B. Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors. J Gerontol Ser A - Biol Sci Med 1995; 50: B378-82.
9. Franceschi C, Monti D, Sansoni P, Cossarizza A. The immunology of exceptional individuals: the lesson of centenarians. Immunol Today 1995; 16: 13-16.
10. Michie CA, McLean A, Alcock C, Beverly PCL. The lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature 1992; 360: 264-65.
11. Zinkernagel RM, Doherty PC. The discovery of MHC restriction. Immunol Today 1997; 18: 12-16.
12. Chatta GS, Dale DC. Aging and haemopoiesis: implications for treatment with haemopoietic growth factors. Drugs Aging 1996; 9: 37-47.
13. Nilsson-Ehle H, Swolin B, Westin J. Bone marrow progenitor cell growth and karyotype changes in healthy 88-year-old subjects. Eur J Haematol 1995; 55: 14-18.
14. Keating A. The haematopoietic stem cell in elderly patients with leukemia. Leukemia 1996; 10: S30-32.
15. Mehr R, Perelson AS, Fridkishareli M, Globerson A. Feedback regulation of T cell development: manifestations in aging. Mech Ageing Dev 1996; 91: 195-210.
16. Zauber NP, Zauber AG. Hematologic data of healthy very old people. JAMA 1987; 257: 2181-84.
17. Steinmann GG, Klaus B, Muller-Hermelink HK. The involution of the ageing human thymic epithelium is independent of puberty: a morphometric study. Scand J Immunol 1985; 22: 562-75.
18. Hartwig M, Steinmann GG. On causal mechanism of chronic thymic involution in man. Mech Ageing Dev 1994; 75: 151-56.
19. Aspinall R. Age-associated thymic atrophy in the mouse is due to a deficiency affecting rearrangement of the TCR during intrathymic T cell development. J Immunol 1997; 158: 3037-45.
20. Thoman ML. The pattern of T lymphocyte differentiation is altered during thymic involution. Mech Ageing Dev 1995; 82: 155-70.
21. + T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995; 332: 143-49.
22. Steinmann GG, Hartwig M. Immunology of centenarians. Immunol Today 1995; 16: 549.
23. Rattan SIS. Ageing - a biological perspective. Mol Aspects Med 1995; 16: 439-508.
24. Effros RB, Pawelec G. Replicative senescence of T lympohocytes: does the Hayflick limit lead to clonal exhaustion? Immunol Today 1997; 18: 450-54.
25. de Bruijn IA, Remarque EJ, Beyer WEP, LeCessie S, Masurel N, Ligthart GJ. Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly. Vaccine 1997; 15: 1323-29.
26. Ahmed R, Gray D. Immunological memory and protective immunity: understanding their relation. Science 1996; 272: 54-60.
27. + T cell compartment. Clin Exp Immunogenet 1992; 9: 195-202.
28. + T cell differentiation in vivo. Clin Exp Immunol 1994; 96: 528-34.
29. Schuurman HJ, Nagelkerken L, de Weger RA, Rozing J. Age-associated involution: significance of a physiologic process. Thymus 1991; 18: 1-6.
30. + helper T cells in human subjects. Aging Immunol Infect Dis 1990; 2: 91-94.
31. Cerottini JC, MacDonald HR. The cellular basis of T-cell memory. Ann Rev Immunol 1989; 7: 77.
32. Vitetta ES, Berton MT, Burger C, Kepron M, Lee WT, Yin XM. Memory B and T cells. Ann Rev Immunol 1991; 9: 193.
33. + T cell subsets in human peripheral blood. Mech Ageing Dev 1992; 63: 57-68.
34. McElhaney JE, Pinkoski MJ, Meneilly GS. Changes in CD45 isoform expression after influenza vaccination. Mech Ageing Dev 1993; 69: 79-91.
35. Effros RB. Insights on immunological aging derived from the T lymphocyte cellular senescence model. Exp Gerontol 1996; 31: 21-27.
36. + are preferentially activated through the CD2 pathway. Eur J Immunol 1988; 18: 1473-76.
37. Byrne JA, Butler JL, Cooper MD. Differential activation requirements for virgin and memory T cells. J Immunol 1988; 141: 3249-57.
38. Sanders ME, Makgoba MW, June CH, Young HA, Shaw S. Enhanced responsiveness of human memory T cells to CD2 and CD3 receptor mediated activation. Eur J Immunol 1989; 19: 803-808.
39. +) human T cells to multiple receptor stimuli but augmentation of responses by co-stimuli. Eur J Immunol 1990; 20: 1111-18.
40. Bettens F, Walker C, Gauchat JF, Gauchat D, Wyss T, Pichledr WJ. Lymphokine gene expression related to CD4 T cell subset (CD45R/CDw29) phenotype conversion. Eur J Immunol 1989; 19: 1569-74.
41. + T cell clones. J Immunol 1989; 143: 907-12.
42. + T cell subsets. Cell Immunol 1992; 141: 10-20.
43. Lewis DB, Prickett KS, Larsen A, Grabstein K, Weaver M, Wilson CB. Restricted production of interleukin 4 by activated human T cells. Proc Natl Acad Sci U S A 1988; 85: 9743-47.
44. +CD45R0+ subset of human T cells. Growth Factors 1992; 6: 295-302.
45. + T cells in CD2-mediated activation. J Exp Med 1990; 172: 1419-24.
46. Mosmann TR, Coffman RL. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol 1989; 46: 111.
47. Powrie F, Coffman RL. Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol Today 1993; 14: 270-74.
48. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17: 138-46.
49. Newport MJ, Huxley CM, Huston S et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996; 335: 1941-49.
50. Jouanguy E, Altare F, Lamhamedi S et al. Interferon-gamma-receptor deficiency in an infant with fatal Bacille Calmette-Guérin infection. N Engl J Med 1996; 335: 1956-61.
51. Zhang Y, Cosyns M, Levin MJ, Hayward AR. Cytokine production in varicella zoster virus-stimulated limiting dilution lymphocyte cultures. Clin Exp Immunol 1994; 98: 128-33.
52. Ligthart GJ, van Vlokhoven PC, Schuit HRE, Hijmans W. The expanded null cell compartment in ageing: increase in the number of natural killer cells and changes in T cell and NK cell subsets in human blood Immunology 1986; 59: 353-57.
53. Makinodan T, Kay MMB. Age influence on the immune system. In: Kunkel HG, Dixon FJ eds. Advances in immunology. New York: Academic Press, 1980: 287-330.
54. Makinodan T, Chang M, Kinohara N. Influence of age on cellular differentiation: a T-cell model. Exp Gerontol 1986; 21: 241-53.
55. Makinodan T, Hahn TJ, McDougall S, Yamaguchi DT, Fang M, Iida-Klein A. Cellular immunosenscence: an overview. Exp Gerontol 1991; 26: 281-88.
56. Callard RE, Basten A. Immune function in aged mice. IV. Loss of T and B cell function in thymus-dependent antibody responses. Eur J Immunol 1978; 8: 552-58.
57. de Greef GE, van Tol MJD, Kallenberg CGM et at. Influence of ageing on antibody formation in vivo after immunisation with the primary T-cell dependent antigen Helix pomatia haemocyanin. Mech Ageing Dev 1992; 66: 15-27.
58. Kalff MW. A population study on serum immunoglobulin levels. Clin Chim Acta 1970; 28: 277-89.
59. de Greef GE, van ToI MJD, van den Berg JWK et al. Serum immunoglobulin class and IgG subclass levels and the occurrence of homogeneous immunoglobulins during the course of ageing. Mech Ageing Dev 1992; 66: 29-44.
60. Schoub BD, Blackburn NK, Johnson S, McAnerney JM, Miller B. Low antibody avidity in elderly chickenpox patients. J Med Virol 1992; 37: 113-15.
61. Kishimoto S, Takahama T, Mizumachi H. In vitro immune response to the 2,4,6-TNP determinant in aged C57BL/6J mice: changes in the humoral immune response, avidity for the TNP determinant and responsiveness to LPS effect with aging. J Immunol 1976; 116: 294.
62. Radl J, Sepers JM, Skvaril F, Morell A, Hijmans W. Immunoglobulin patterns in humans over 95 years of age. Clin Exp Immunol 1975; 22: 84.
63. Benner R, Hijmans W, Haaijman JJ. The bone marrow: the major source of serum immunoglobulins, but still a neglected site of antibody formation. Clin Exp Immunol 1981; 46: 1-8.
64. Ligthart GJ, Radl J, Corberand JX et al. Monoclonal gammopathies in human aging: increased occurrence with age and correlation with health status. Mech Ageing Dev 1990; 52: 235-43.
65. Mariotti S, Sansoni P, Barbesino G et al. Thyroid and other organ-specific autoantibodies in healthy centenarians. Lancet 1992; 339: 1506-508.
66. Ligthart GJ, Schuit HRE, Hijmans W. Natural killer cell function is not diminished in the healthy aged and is proportional to the number of NK cells in the peripheral blood. Immunology 1989; 68: 396-402.
67. La Croix AZ, Lipson S, Miles TP, Whilte L. Prospective study of pneumonia hospitalization and mortality of US older people: the role of chronic conditions, health behaviours, and nutritional status. Public Health Rep 1989; 104: 350-60.
68. Jokinen C, Heiskanen L, Juvonen H et al. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol 1993; 137: 977-88.
69. Chattopadhyay B, Al-Zahawi M. Septicaemia and its unacceptably high mortality in the elderly. J Infect 1983; 7: 134-38.
70. Gorse GJ, Thrupp LD, Nudleman KL, Wyle FA, Hawkins B, Cesario TC. Bacterial meningitis in the elderly. Arch Intern Med 1984; 144: 1603-607.
71. Orr PH, Nicolle LE, Duckworth H et al. Febrile urinary infection in the institutionalized elderly. Am J Med 1996; 100: 71-77.
72. Ackermann RJ, Monroe PW. Bacteremic urinary tract infection in older people. J Am Geriatr Soc 1996; 44: 927-33.
73. Falsey AR, Cunningham CK, Barker WH et al. Respiratory syncytial virus and influenza A infections in the hospitalized elderly. J Infect Dis 1995; 172: 389-94.
74. Barker WH, Mullooly JP. Impact of epidemic type A influenza in a defined adult population. Am J Epidemiol 1980; 112: 798-813.
75. Sprenger MJW, Mulder PGH, Beyer WEP, van Strik R, Masurel N. Impact of influenza on mortality in relation to age and underlying disease, 1967-1989. Int J Epidemiol 1993; 22: 334-40.
76. MacGee W. Causes of death in a hospitalized geriatric population: an autopsy study of 3000 patients. Virchows Arch A Pathol Anat 1993; 423: 343-49.
77. Chandra RK. Effect of vitamin and trace-element supplementation on immune responses and infection in elderly subjects. Lancet 1992; 340: 1124-27.
78. Roebothan BV, Chandra RK. Relationship between nutritional status and immune function in elderly people. Age and Ageing 1994; 23: 49-53.
79. Pike J, Chandra RK. Effect of vitamin and trace element supplementation on immune indices in healthy elderly. Int J Vit Nutr Res 1995; 65: 117-20.
80. Straus SE. Overview: the biology of varicellazoster infection. Ann Neurol 1994; 35 (suppl): S4-8.
81. Berger R, Florent G, Just M. Decrease of the lymphoproliferative response to varicella zoster virus antigen in the aged. Infect Immunol 1981; 32: 24-27.
82. Gergen PJ, McQuillan GM, Kiely M, Ezzati-Rice TM, Sutter RW, Virella G. A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med 1995; 332: 761-66.
83. Kikuchi R, Watabe N, Konno T, Mishina N, Sekizawa K, Sasaki H. High incidence of silent aspiration in elderly patients with community-acquired pneumonia. Am J Respir Crit Care Med 1994; 150: 251-53.
84. Pick N, McDonald A, Bennett N et al. Pulmonary aspiration in a long-term care setting: clinical and laboratory observations and an analysis of risk factors. J Am Geriatr Soc 1996; 44: 763-68.
85. Yoneyama T, Hashimoto K, Fukuda H et al. Oral hygiene reduces respiratory infections in elderly bed-bound nursing home patients. Arch Gerontol Geriatr 1996; 22: 11-19.
86. Schneider EL. Infectious diseases in the elderly. Ann Intern Med 1983; 98: 395-400.
87. Gardner ID. The effect of aging on the susceptibility to infection. Rev Infect Dis 1980; 5: 801-10.
88. Garibaldi RA, Brodine S, Matsumiya S. Infections among patients in nursing homes. N Engl J Med 1981; 305: 731-35.
89. Stein BE. Vaccinating elderly people. Protecting from avoidable disease. Drugs Aging 1994; 5: 242-53.
90. Bentley DW. Immunizations in the elderly. Bull N Y Acad Med 1987; 63: 533-51.
91. Barker WH, Mullooly JP. Influenza vaccination of elderly persons: reduction in pneumonia and influenza hospitalizations and deaths. JAMA 1980; 244: 2547-49.
92. Nichol KL, Margolis KL, Wuorenma J, Von Sternberg TL. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994; 331: 778-84.
93. Beyer WEP, Palache AM, Baljet M, Masurel N. Antibody induction by influenza vaccines in the elderly: a review of the literature. Vaccine 1989; 7: 385-94.
94. McElhaney JE, Meneilly GS, Lechelt KE, Beattie BL, Bleackley RC. Antibody response to whole-virus and split-virus influenza vaccines in successful ageing. Vaccine 1993; 11: 1055-60.
95. Powers DC, Belshe RB. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine. J Infect Dis 1993; 167: 584-92.
96. Remarque EJ, Nijhuis EWP, Hinloopen B, Nagelkerken L, van der Velde EA, Ligthart GJ. Correlation between the antibody response to influenza vaccine and helper T cell subsets in healthy ageing. Vaccine 1993; 14: 127-30.
97. Pyhälä R, Kinnunen L, Kumpulainen V, Ikonen N, Kleemola M, Cantell K. Vaccination-induced HI antibody to influenza A(H1N1) viruses in poorly primed adults under circumstances of low antigenic drift. Vaccine 1993; 11: 1013-17.
98. Powers DC, Belshe RB. Vaccine-induced antibodies to heterologous influenza A H1N1 viruses: effects of aging and 'original antigenic sin'. J Infect Dis 1994; 169: 1125-29.
99. Remarque EJ, Cools HJM, Boere TJ, van der Klis RJ, Masurel N, Ligthart GJ. Functional disability and antibody response to influenza vaccine in elderly patients in a Dutch nursing home. BMJ 1996; 312: 1015.
100. Pawelec G, Adibzadeh M, Solana R, Beckman I. The T cell in the ageing individual. Mech Ageing Dev 1997; 93: 35-45.